Orthopedic surgery or orthopedics (also spelled orthopaedics) is the branch of surgery concerned with conditions involving the musculoskeletal system. Orthopedic surgeons use both surgical and non-surgical means to treat musculoskeletal trauma, sports injuries, degenerative diseases, infections, tumors, and congenital conditions.
New technologies may offer new treatment options for some patients with degenerative back problems, according to research presented at the 72nd Annual Meeting of the American Academy of Orthopaedic Surgeons. These latest innovations in spinal surgery could provide promise for hundreds of thousands of U.S. patients who undergo spinal surgery each year.
New research presented today at the 72nd Annual Meeting of the American Academy of Orthopaedic Surgeons includes important findings on the causes of anterior cruciate ligament (ACL) injuries in female athletes, such as posture and body movement. These findings may be key in the effort to find ways to prevent these types of injuries.
New imaging technologies are enabling doctors to not only diagnose a variety of orthopaedic and musculoskeletal conditions with more accuracy, but also to determine with unprecedented precision whether clinical recovery from bone, joint or tendon damage is actually complete and not simply a "placebo effect."
Two separate new studies presented at a major medical meeting provide objective scientific evidence that the two most commonly performed cartilage repair techniques are effective at restoring patient mobility and reducing pain.
Leaping tall buildings in a single bound may be out of the question, but the genetically engineered "supermice" in Ormond MacDougald's laboratory at the University of Michigan Medical School are definitely stronger than average.
Duke University Medical Center researchers have found that joints whose cartilage lacks a specific type of collagen will develop osteoarthritis – the so-called "wear-and-tear" form of the disease – at a greatly accelerated rate.
Adhesions – bands of scar tissue that bind together two internal body surfaces – develop in 55 percent to more than 90 percent of patients undergoing surgery, depending on the type of operation. They are part of normal healing, but when surfaces fuse together that shouldn't, serious pain and complications can result.
Genzyme announced today that it has filed a lawsuit in the District Court of Tel Aviv alleging that Transkaryotic Therapies Inc. has infringed Genzyme's Israeli patent No. 100,715, which covers certain cell culture processes involved in the manufacture of glucocerebrosidase.
Corticosteroids can be beneficial in the treatment of Duchenne muscular dystrophy and can be offered as a treatment option, according to the American Academy of Neurology and the Child Neurology Society in a new practice guideline published in the January 11 issue of Neurology, the scientific journal of the American Academy of Neurology.
A new material that fuses biological and synthetic substances at the molecular level speeds bone and cartilage repair. Its creators at the Technion-Israel Institute of Technology say laboratory studies have shown the new gel promotes healing by gluing bone pieces together and stimulating tissue development.
A remarkable story of how a new disease was inadvertently caused by successful medical treatment, ultimately understood, and eventually defeated by scientific innovation is being told a major player in the process.
As many as 28,000 patients die each year in the U.S. because of catheter-related bloodstream infections, but doctors and nurses who implement simple and inexpensive interventions can cut the number of deaths to nearly zero, according to a study by Johns Hopkins researchers.
CT with multiplanar reconstruction provides a clear multi-dimensional view of tibial triplane fractures of the ankle--a view that alters what is found in many medical textbooks and changes the way physicians understand these complex fractures, a new study shows.
Competitive Technologies announced today that patent number 6,808,561 has been issued by the US Patent Office for Dr. Brian R. Genge's nanotechnology bone biomaterial developed at the University of South Carolina (USC).
Although medical rehabilitation patients are spending less time as inpatients at facilities, their functional outcomes have not declined. However, the death rate following discharge has increased nearly 4 percent from 1994 to 2001, according to a study in the October 13 issue of JAMA.
Hapto-Biotech, an Israeli start-up company, and New York-based Ortec International Inc., have joined forces to develop a bandage capable of healing wounds and regenerating tissue, using a unique combination of peptides and collagen.
When heart failure patients undergo surgery for other health problems, they are much more likely to die or suffer complications than similar patients who have coronary artery disease
Broken bones often mean lifelong disability in the developing world, due to a lack of access to simple, inexpensive initial treatment, says the director of the University of Toronto's international surgery program.
Citing improved safety and effectiveness at lower cost, a major medical center has adopted the microdebrider to replace the CO2 laser for removal of most pediatric airway lesions, including stenoses, granulation tissue, and cysts.
The Vertical Expandable Prosthetic Titanium Rib (VEPTR), a device that has saved the lives of 300 infants and young children who otherwise would have died from lack of breath, has been approved by the U.S. Food and Drug Administration (FDA).